FindTrial
Sign In

Detection and Analysis of Cardiovascular diseases using photoplethysmographic signals.

Study of Photoplethysmography based Pulse Transit Time and Augmentation Index in healthy subjects and patients for Detection and Analysis of Cardiovascular diseases.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028665
Enrollment
100
Registered
2020-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases

Interventions

Intervention1: NIL: NIL Intervention2: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Indian Institute of Technology Kharagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients typical clinical history, 2. ECG showing STEMI, 3. Biomarker of myonecrosis, 4. Echo-Doppler study showing RWMA 5. CAG showing stenosis of varying severities. 6. ECG and TMT evidence IHD

Exclusion criteria

Exclusion criteria: 1. Suffering from septicemia, renal insufficiency and diabetes mellitus 2. Aortic valve replacement or defect on the septum. 3. Primary or secondary acquired/congenital other structural heart diseases 4. Ejection fraction less than 35. 5. Hypertension (SBP 100-stage three category). 6. Heart rate greater than 100 beats per minute (tachycardia).

Design outcomes

Primary

MeasureTime frame
Photoplethysmography signal collections are possible from patientsTimepoint: First time point-six months after data collection (Jan 2021) i.e. August 2021 and Second time point one ear after data collection i.e. Jan 2022—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Bhabani Prasad Chattopadhyay

Indian Institute of Technology, Kharagpur

poulomi2@iitkgp.ac.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026